Kuangli Bio-Tech Holdings Co., Ltd.(TW:6431)
NT$14.55-0.30 (-2.02%)
TW:6431
Kuangli Bio-Tech Holdings Co., Ltd. financials statements
NT$14.55
At close:-0.30 (-2.02%)
Kuangli Bio-Tech Holdings Co., Ltd. (6431) Ratios
Kuangli Bio-Tech Holdings Co., Ltd. Ratios
TW:6431's free cash flow for Q2 2026 was NT$-60.99M. For the 2026 fiscal year, TW:6431's free cash flow was decreased by NT$-988.30K and operating cash flow was NT$-60.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.36 | 0.81 | 1.08 | 1.47 | 1.59 |
| Quick Ratio | 1.22 | 0.62 | 0.87 | 1.24 | 1.30 |
| Cash Ratio | 0.61 | 0.14 | 0.22 | 0.52 | 0.49 |
| Solvency Ratio | -0.17 | -0.20 | -0.09 | -0.02 | 0.19 |
| Operating Cash Flow Ratio | -0.42 | -0.21 | -0.22 | -0.03 | 0.07 |
| Short-Term Operating Cash Flow Coverage | -0.79 | -0.40 | -0.33 | -0.06 | 0.15 |
| Net Current Asset Value | NT$ -143.17M | NT$ -201.03M | NT$ -179.64M | NT$ -43.02M | NT$ 16.50M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.41 | 0.37 | 0.40 | 0.31 | 0.28 |
| Debt-to-Equity Ratio | 0.84 | 0.73 | 0.76 | 0.52 | 0.72 |
| Debt-to-Capital Ratio | 0.46 | 0.42 | 0.43 | 0.34 | 0.42 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.01 | 0.04 | 0.02 | 0.00 |
| Financial Leverage Ratio | 2.06 | 1.98 | 1.87 | 1.66 | 2.59 |
| Debt Service Coverage Ratio | -0.47 | -0.41 | -0.14 | 0.03 | 0.66 |
| Interest Coverage Ratio | -11.49 | -8.70 | -8.02 | -4.91 | 7.88 |
| Debt to Market Cap | 0.08 | 0.17 | 0.20 | 0.15 | 0.11 |
| Interest Debt Per Share | 5.37 | 5.14 | 7.61 | 6.46 | 7.02 |
| Net Debt to EBITDA | -3.01 | -3.57 | -7.33 | -21.98 | 1.73 |
| Profitability Margins | |||||
| Gross Profit Margin | 18.68% | 17.92% | 22.60% | 20.07% | 25.56% |
| EBIT Margin | -47.57% | -43.67% | -37.32% | -20.52% | 18.88% |
| EBITDA Margin | -24.52% | -21.66% | -16.65% | -2.76% | 30.02% |
| Operating Profit Margin | -41.77% | -36.21% | -38.74% | -20.52% | 18.06% |
| Pretax Profit Margin | -51.20% | -47.83% | -42.16% | -24.78% | 16.96% |
| Net Profit Margin | -51.20% | -45.32% | -35.51% | -20.75% | 15.62% |
| Continuous Operations Profit Margin | -51.20% | -45.32% | -35.51% | -20.67% | 15.25% |
| Net Income Per EBT | 100.00% | 94.73% | 84.22% | 83.75% | 92.10% |
| EBT Per EBIT | 122.58% | 132.10% | 108.82% | 120.72% | 93.89% |
| Return on Assets (ROA) | -16.26% | -18.98% | -9.98% | -6.36% | 4.48% |
| Return on Equity (ROE) | -33.43% | -37.57% | -18.67% | -10.55% | 11.60% |
| Return on Capital Employed (ROCE) | -18.64% | -22.93% | -14.95% | -8.33% | 7.03% |
| Return on Invested Capital (ROIC) | -14.72% | -16.36% | -9.75% | -5.75% | 5.45% |
| Return on Tangible Assets | -20.49% | -27.12% | -13.98% | -9.04% | 6.17% |
| Earnings Yield | -7.70% | -17.38% | -10.11% | -6.19% | 4.05% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.58 | 3.31 | 2.16 | 2.10 | 1.55 |
| Payables Turnover | 6.24 | 5.54 | 10.16 | 9.22 | 2.80 |
| Inventory Turnover | 6.59 | 5.45 | 3.91 | 4.36 | 2.74 |
| Fixed Asset Turnover | 0.90 | 1.19 | 0.77 | 0.94 | 0.95 |
| Asset Turnover | 0.32 | 0.42 | 0.28 | 0.31 | 0.29 |
| Working Capital Turnover Ratio | 12.01 | -21.09 | 3.92 | 2.12 | 2.25 |
| Cash Conversion Cycle | 76.60 | 111.34 | 226.45 | 218.37 | 238.91 |
| Days of Sales Outstanding | 79.71 | 110.25 | 169.03 | 174.15 | 235.88 |
| Days of Inventory Outstanding | 55.43 | 67.02 | 93.36 | 83.81 | 133.27 |
| Days of Payables Outstanding | 58.53 | 65.93 | 35.93 | 39.59 | 130.24 |
| Operating Cycle | 135.13 | 177.27 | 262.38 | 257.96 | 369.15 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.56 | -0.95 | -1.09 | -0.16 | 0.43 |
| Free Cash Flow Per Share | -1.66 | -1.21 | -1.53 | -0.77 | -0.37 |
| Dividend Paid and CapEx Coverage Ratio | -15.89 | -3.74 | -2.47 | -0.27 | 0.53 |
| Capital Expenditure Coverage Ratio | -15.89 | -3.74 | -2.47 | -0.27 | 0.53 |
| Operating Cash Flow Coverage Ratio | -0.30 | -0.19 | -0.15 | -0.03 | 0.06 |
| Operating Cash Flow to Sales Ratio | -0.39 | -0.17 | -0.21 | -0.03 | 0.06 |
| Free Cash Flow Yield | -6.16% | -8.31% | -8.50% | -3.79% | -1.37% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -13.00 | -5.75 | -9.89 | -16.15 | 24.73 |
| Price-to-Sales (P/S) Ratio | 6.65 | 2.61 | 3.51 | 3.35 | 3.86 |
| Price-to-Book (P/B) Ratio | 4.34 | 2.16 | 1.85 | 1.71 | 2.86 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -16.23 | -12.03 | -11.76 | -26.40 | -73.05 |
| Price-to-Operating Cash Flow Ratio | -17.26 | -15.24 | -16.52 | -124.14 | 63.69 |
| Price-to-Earnings Growth (PEG) Ratio | 0.73 | -0.15 | -0.22 | 0.08 | -0.14 |
| Enterprise Value Multiple | -30.13 | -15.61 | -28.42 | -143.31 | 14.58 |
| Enterprise Value | 2.79B | 1.29B | 1.39B | 1.36B | 1.57B |
| EV to EBITDA | -30.13 | -15.61 | -28.42 | -143.31 | 14.58 |
| EV to Sales | 7.39 | 3.38 | 4.73 | 3.96 | 4.38 |
| EV to Free Cash Flow | -18.04 | -15.60 | -15.85 | -31.19 | -82.89 |
| EV to Operating Cash Flow | -19.17 | -19.77 | -22.26 | -146.63 | 72.27 |
| Tangible Book Value Per Share | 3.60 | 2.72 | 4.54 | 6.08 | 7.89 |
| Shareholders’ Equity Per Share | 6.19 | 6.71 | 9.75 | 11.93 | 9.50 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.05 | 0.16 | 0.16 | 0.08 |
| Revenue Per Share | 4.04 | 5.56 | 5.13 | 6.07 | 7.05 |
| Net Income Per Share | -2.07 | -2.52 | -1.82 | -1.26 | 1.10 |
| Tax Burden | 1.00 | 0.95 | 0.84 | 0.84 | 0.92 |
| Interest Burden | 1.08 | 1.10 | 1.13 | 1.21 | 0.90 |
| Research & Development to Revenue | 0.09 | 0.08 | 0.10 | 0.09 | 0.03 |
| SG&A to Revenue | 0.49 | 0.46 | 0.51 | 0.37 | 0.26 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.75 | 0.36 | 0.60 | 0.11 | 0.44 |
Currency in TWD
